Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Sales (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of Return on Sales data on record, last reported at 0.44% in Q4 2025.

  • For Q4 2025, Return on Sales fell 41.0% year-over-year to 0.44%; the TTM value through Dec 2025 reached 0.55%, up 56.0%, while the annual FY2025 figure was 0.55%, 56.0% up from the prior year.
  • Return on Sales reached 0.44% in Q4 2025 per TGTX's latest filing, down from 2.42% in the prior quarter.
  • Across five years, Return on Sales topped out at 1136.44% in Q4 2022 and bottomed at 389.49% in Q3 2022.
  • Average Return on Sales over 5 years is 19.37%, with a median of 0.37% recorded in 2023.
  • Peak YoY movement for Return on Sales: skyrocketed 227720bps in 2021, then plummeted -113674bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 40.51% in 2021, then skyrocketed by 2905bps to 1136.44% in 2022, then crashed by -100bps to 0.31% in 2023, then skyrocketed by 91bps to 0.03% in 2024, then tumbled by -1421bps to 0.44% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.44% in Q4 2025, 2.42% in Q3 2025, and 0.2% in Q2 2025.